bibliographicCitation |
Aliferis K, Petropoulos IK, Farpour B, Matter MA, Safran AB. Should central serous chorioretinopathy be added to the list of ocular side effects of phosphodiesterase 5 inhibitors? Ophthalmologica. 2012;227(2):85–9. doi: 10.1159/000333824. PMID: 22156704. |